Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Delivery Devices

PUBLISHER: Grand View Research | PRODUCT CODE: 1529625

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1529625

Insulin Delivery Devices Market Size, Share & Trends Analysis Report By Product (Reusable Insulin Pens, Disposable Insulin Pens), By End Use (Hospitals & Clinics, Homecare), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Insulin Delivery Devices Market Growth & Trends:

The global insulin delivery devices market size was estimated at USD 28.06 billion in 2030 and is expected to grow at a CAGR of 7.89% from 2024 to 2030. Obesity, sedentary lifestyles, and unhealthy food habits, primarily in the young population, lead to the occurrence of diabetes. In addition, the growing diabetic geriatric population is another factor supporting the growth of this vertical. According to the United Nations, Department of Economic and Social Affairs, around 901 million individuals were aged 60 or over in 2015 and this number is projected to increase to 1.4 billion by 2030. Thus, the enlarging elderly population is expected to boost the demand for insulin delivery devices.

Technological innovations and advancements are an ongoing trend in this vertical. The high demand for advanced insulin delivery devices is supporting the adoption of recently launched innovative pen devices and portable pumps, which is estimated to boost the market growth. Also, favorable reimbursement policies for these devices, mainly in developed countries like the U.S. and Germany, are anticipated to fuel the market growth during the study period. However, stringent regulatory requirements regulating the approval of insulin delivery devices and the high cost of insulin analogs in diabetes care management are major factors restraining the growth of this industry.

The market's prominent competitors are taking different initiatives such as acquisition, funding, and product development to expand their product portfolio and enhance their manufacturing capacity. For instance, in October 2021, Eli Lilly partnered with Cipla, to market its Insulin products (Humalog and Trulicity) in India. Additionally, In June 2021, the company acquired Protomer Technologies, to strengthen its market presence. Further, Novo Nordisk, joined hands with Biocorp to develop a Bluetooth-enabled smart add-on device for their pen insulin injector.

Insulin Delivery Devices Market Report Highlights:

  • The insulin pens segment was the largest revenue-generating category of this market in 2021. The pen is equipped with self-contained cartridges and offers ease in handling and less pain while injecting insulin. The advantages of these pen devices over other products are resulting in their growing popularity, thus serving as a vital factor in contributing to the sectorb s highest share in this market
  • The home care segment is estimated to be the fastest-growing segment due to increased adoption of self-care diabetes management devices and the availability of simplified and user-friendly product designs for patients
  • North America is the leading regional sector and accounted for the largest revenue share in 2021 primarily due to the favorable reimbursement scenario in this space. Also, the presence of major manufacturers in this region is supporting market growth
  • In Asia Pacific, the market is anticipated to grow fast during the forecast period. The high prevalence rate of diabetes in countries, such as China and India, is a major factor contributing to market expansion in this region
Show more
Product Code: GVR-1-68038-991-3

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Insulin Delivery Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rise in the prevalence of diabetes globally
      • 3.2.1.2. Increasing geriatric population
      • 3.2.1.3. Favorable government reimbursement scenario
      • 3.2.1.4. Increasing awareness about diabetes preventive care
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulatory framework
      • 3.2.2.2. High cost of devices
  • 3.3. Insulin Delivery Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Insulin Delivery Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Insulin Delivery Devices Product Market Movement Analysis
  • 4.3. Global Insulin Delivery Devices Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Insulin Pens
    • 4.4.1. Insulin pens market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Reusable Insulin Pens
      • 4.4.2.1. Reusable insulin pens market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Disposable Insulin Pens
      • 4.4.3.1. Disposable insulin pens market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Insulin Pumps
    • 4.5.1. Insulin pumps market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Patch Pumps
      • 4.5.2.1. Patch pumps market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Tethered Pumps
      • 4.5.3.1. Tethered pumps market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Insulin Pen Needles
    • 4.6.1. Insulin pen needles market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Standard Pen Needles
      • 4.6.2.1. Standard pen needles market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Safety Pen Needles
      • 4.6.3.1. Safety pen needles market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Insulin Syringes
  • 4.8. Other Products

Chapter 5. Insulin Delivery Devices Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Insulin Delivery Devices End Use Market Movement Analysis
  • 5.3. Global Insulin Delivery Devices Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals & Clinics
    • 5.4.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Homecare
    • 5.5.1. Homecare market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Other End User
    • 5.6.1. Other End Users market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Insulin Delivery Devices Market: Regional Estimates & Trend Analysis By Product, End Use

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. Reimbursement structure
      • 6.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement structure
      • 6.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement structure
      • 6.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Reimbursement structure
      • 6.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement structure
      • 6.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement structure
      • 6.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Competitive scenario
      • 6.6.4.3. Regulatory framework
      • 6.6.4.4. Reimbursement structure
      • 6.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Competitive scenario
      • 6.6.5.3. Regulatory framework
      • 6.6.5.4. Reimbursement structure
      • 6.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Competitive scenario
      • 6.6.6.3. Regulatory framework
      • 6.6.6.4. Reimbursement structure
      • 6.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Competitive scenario
      • 6.6.7.3. Regulatory framework
      • 6.6.7.4. Reimbursement structure
      • 6.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Competitive scenario
      • 6.6.8.3. Regulatory framework
      • 6.6.8.4. Reimbursement structure
      • 6.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement structure
      • 6.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement structure
      • 6.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement structure
      • 6.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement structure
      • 6.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement structure
      • 6.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement structure
      • 6.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement structure
      • 6.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement structure
      • 6.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement structure
      • 6.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement structure
      • 6.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement structure
      • 6.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Competitive scenario
      • 6.9.4.3. Regulatory framework
      • 6.9.4.4. Reimbursement structure
      • 6.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share analysis, 2023
  • 7.4. Company Position Analysis
  • 7.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 7.6. Company Profiles
    • 7.6.1. Novo Nordisk A/S
      • 7.6.1.1. Company overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Product benchmarking
      • 7.6.1.4. Strategic initiatives
    • 7.6.2. Sanofi
      • 7.6.2.1. Company overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Strategic initiatives
    • 7.6.3. Eli Lilly and Company
      • 7.6.3.1. Company overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Strategic initiatives
    • 7.6.4. Ypsomed AG
      • 7.6.4.1. Company overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Strategic initiatives
    • 7.6.5. Medtronic
      • 7.6.5.1. Company overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Strategic initiatives
    • 7.6.6. Insulet Corporation
      • 7.6.6.1. Company overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Strategic initiatives
    • 7.6.7. B. Braun SE
      • 7.6.7.1. Company overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Product benchmarking
      • 7.6.7.4. Strategic initiatives
    • 7.6.8. Owen Mumford Ltd.
      • 7.6.8.1. Company overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Product benchmarking
      • 7.6.8.4. Strategic initiatives
    • 7.6.9. Tandem Diabetes Care, Inc.
      • 7.6.9.1. Company overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Product benchmarking
      • 7.6.9.4. Strategic initiatives
      • 7.6.9.5. Company overview
    • 7.6.10. BD
      • 7.6.10.1. Company overview
      • 7.6.10.2. Financial performance
      • 7.6.10.3. Product benchmarking
      • 7.6.10.4. Strategic initiatives
      • 7.6.10.5. Company overview
Show more
Product Code: GVR-1-68038-991-3

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America insulin delivery devices market, By country, 2018 - 2030 (USD Million)
  • Table 4 North America insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 5 North America insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 7 U.S insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 8 Canada insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 9 Canada insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 10 Mexico insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 11 Mexico insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe insulin delivery devices market, By country, 2018 - 2030 (USD Million)
  • Table 13 Europe insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 14 Europe insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 15 UK insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 16 UK insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 17 Germany insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 18 Germany insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 19 France insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 20 France insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 21 Italy insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 22 Italy insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 23 Denmark insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 24 Denmark insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 25 Sweden insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 26 Sweden insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 27 Norway insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 28 Norway insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific insulin delivery devices market, By country, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 32 Japan insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 33 Japan insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 34 China insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 35 China insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 36 India insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 37 India insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 38 Australia insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 39 Australia insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 40 South Korea insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 41 South Korea insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 42 Thailand insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 43 Thailand insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 44 Latin America insulin delivery devices market, By Country, 2018 - 2030 (USD Million)
  • Table 45 Latin America insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 46 Latin America insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 47 Brazil insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 48 Brazil insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 49 Argentina insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 50 Argentina insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 51 Middle East & Africa insulin delivery devices market, By country, 2018 - 2030 (USD Million)
  • Table 52 Middle East & Africa insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 53 Middle East & Africa insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 54 South Africa insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 55 South Africa insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 58 UAE insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 59 UAE insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 60 Kuwait insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 61 Kuwait insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Insulin delivery devices market: market outlook
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 Penetration and growth prospect mapping
  • Fig. 17 Industry value chain analysis
  • Fig. 18 Insulin delivery devices market driver impact
  • Fig. 19 Insulin delivery devices market restraint impact
  • Fig. 20 Insulin delivery devices market: Product movement analysis
  • Fig. 21 Insulin delivery devices market: Product outlook and key takeaways
  • Fig. 22 Insulin pens market estimates and forecast, 2018 - 2030
  • Fig. 23 Reusable insulin pens market estimates and forecast, 2018 - 2030
  • Fig. 24 Disposable insulin pens market estimates and forecast, 2018 - 2030
  • Fig. 25 Insulin pumps market estimates and forecast, 2018 - 2030
  • Fig. 26 Patch pumps market estimates and forecast, 2018 - 2030
  • Fig. 27 Tethered pumps market estimates and forecast, 2018 - 2030
  • Fig. 28 Insulin pen needles market estimates and forecast, 2018 - 2030
  • Fig. 29 Standard pen needles market estimates and forecast, 2018 - 2030
  • Fig. 30 Safety pen needles market estimates and forecast, 2018 - 2030
  • Fig. 31 Insulin syringes market estimates and forecast, 2018 - 2030
  • Fig. 32 Other products market estimates and forecast, 2018 - 2030
  • Fig. 33 Insulin delivery devices market: End use movement analysis
  • Fig. 34 Insulin delivery devices market: End use outlook and key takeaways
  • Fig. 35 Hospitals and clinics market estimates and forecast, 2018 - 2030
  • Fig. 36 Homecare market estimates and forecast, 2018 - 2030
  • Fig. 37 Others end users market estimates and forecast, 2018 - 2030
  • Fig. 38 Global insulin delivery devices market: Regional movement analysis
  • Fig. 39 Global insulin delivery devices market: Regional outlook and key takeaways
  • Fig. 40 North America
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030
  • Fig. 42 U.S.
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 44 Canada
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 46 Mexico
  • Fig. 47 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 48 Europe
  • Fig. 49 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 50 UK
  • Fig. 51 UK market estimates and forecasts, 2018 - 2030
  • Fig. 52 Germany
  • Fig. 53 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 54 France
  • Fig. 55 France market estimates and forecasts, 2018 - 2030
  • Fig. 56 Italy
  • Fig. 57 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 58 Spain
  • Fig. 59 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 60 Denmark
  • Fig. 61 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 62 Sweden
  • Fig. 63 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 64 Norway
  • Fig. 65 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 66 Asia Pacific
  • Fig. 67 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 68 China
  • Fig. 69 China market estimates and forecasts, 2018 - 2030
  • Fig. 70 Japan
  • Fig. 71 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 72 India
  • Fig. 73 India market estimates and forecasts, 2018 - 2030
  • Fig. 74 Thailand
  • Fig. 75 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 76 South Korea
  • Fig. 77 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 78 Australia
  • Fig. 79 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 80 Latin America
  • Fig. 81 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 82 Brazil
  • Fig. 83 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 84 Mexico
  • Fig. 85 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 86 Argentina
  • Fig. 87 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 88 Middle East and Africa
  • Fig. 89 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 90 South Africa
  • Fig. 91 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 92 Saudi Arabia
  • Fig. 93 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 94 UAE
  • Fig. 95 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 96 Kuwait
  • Fig. 97 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 98 Market share of key market players- Insulin delivery devices market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!